Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enovis (ENOV) Cash & Equivalents (2016 - 2025)

Enovis (ENOV) has disclosed Cash & Equivalents for 16 consecutive years, with $36.4 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 24.45% to $36.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36.4 million through Dec 2025, down 24.45% year-over-year, with the annual reading at $36.4 million for FY2025, 24.45% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $36.4 million at Enovis, up from $33.6 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $763.7 million in Q2 2021, with the low at $21.9 million in Q1 2023.
  • Average Cash & Equivalents over 5 years is $149.0 million, with a median of $41.3 million recorded in 2025.
  • The sharpest move saw Cash & Equivalents surged 600.8% in 2021, then crashed 96.69% in 2023.
  • Over 5 years, Cash & Equivalents stood at $680.3 million in 2021, then tumbled by 96.43% to $24.3 million in 2022, then surged by 48.96% to $36.2 million in 2023, then surged by 33.09% to $48.2 million in 2024, then decreased by 24.45% to $36.4 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $36.4 million, $33.6 million, and $44.1 million for Q4 2025, Q4 2025, and Q3 2025 respectively.